Techno Trends
Merck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
HAPPYneuron will be available for inclusion in Merck’s MSdialog platform for use with Rebif® (interferon beta-1a) Agreement provides Merck with exclusive license to...
News
Shire Receives FDA Breakthrough Therapy Designation for SHP621 and SHP625
Shire plc announced that the U.S. FDA has granted Breakthrough Therapy Designation for two investigational products for rare diseases: SHP621 (budesonide oral suspension, or...
Press Releases
Ziarco Pharma Ltd reports positive Phase 2a study results with ZPL-389
Ziarco Pharma Ltd a biopharmaceutical company focusing on the development of novel drugs for the treatment of inflammatory skin disorders, today announces positive, full...
News
Pfizer Announces Final Results From Inotuzumab Ozogamicin Pivotal Phase 3 Study With Refractory Acute Lymphoblastic Leukemia
Pfizer Inc announced the publication of findings from the Phase 3 INO-VATE ALL study in the online issue of The New England Journal of...
Press Releases
ViiV Healthcare announces FDA approval to lower the weight limit for dolutegravir in children and adolescents living with HIV
ViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg oral tablets, reducing the...
Industry Reports
Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28
Bristol-Myers Squibb Company will announce results for the second quarter of 2016 on Thursday, July 28, 2016. During a conference call at 10:30 a.m....
Press Releases
PCI Pharma Services’ Hay-on-Wye Site Launches New 3D Camera Technology from Scanware
PCI Pharma Services is installing specialist, innovative three-dimensional (3D) and high resolution color camera technology for product inspection and fill control on three of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read